Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to confirm that treatment with oral semaglutide does not result in an unacceptable increase in cardiovascular risk compared to placebo (rule out 80% excess risk) in subjects with type 2 diabetes at high risk of cardiovascular events
Inclusion criteria
- Diabetes Mellitus, Type 2